Additionally, ETS2high patients with AML were more likely to have a higher expression of MN1, miR155HG and WT1 than ETS2low patients (P = 0.04, P < 0.001, and P = 0.009, respectively). The gene discussed is WT1; the disease is acute myeloid leukemia.